| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911150 | Lung Cancer | 2014 | 7 Pages |
Abstract
In a large cohort of patients with predominantly advanced or metastatic NSCLC, none of eight tested immunohistochemical biomarkers predicted the chemotherapy response or survival. Our data indicate limited usefulness of protein biomarkers in metastatic NSCLC and a need for further research based on molecular signatures of greater complexity.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anne-Claire Toffart, Jean-François Timsit, Sébastien Couraud, Patrick Merle, Denis Moro-Sibilot, Maurice Perol, Bénédicte Mastroianni, Pierre-Jean Souquet, Nicolas Girard, Gaëlle Jeannin, Philippe Romand, Patrick Chatellain, Aurélien Vesin,